FNY Investment Advisers’s Spark Therapeutics, Inc. Common Stock ONCE Stock Holding History
Bought
Maintained
Sold
FNY Investment Advisers's ONCE Position: Q4 2019 in Review
FNY Investment Advisers sold out of Spark Therapeutics, Inc. Common Stock (ONCE) in Q4 2019, closing a stake of 86,305 shares — an estimated $8.37M sold.
FNY Investment Advisers first reported a position in ONCE in Q1 2019 and held it in 3 quarters. The position peaked at $31.9M in Q1 2019. 0 funds tracked by Wall St. Rank hold ONCE as of Q4 2019.
- FNY Investment Advisers reported no remaining Spark Therapeutics, Inc. Common Stock position as of Q4 2019 after selling out during the quarter.
- FNY Investment Advisers sold 86,305 Spark Therapeutics, Inc. Common Stock shares in Q4 2019, an estimated $8.37M.
- FNY Investment Advisers first reported a position in Spark Therapeutics, Inc. Common Stock in Q1 2019 and held it in 3 quarters.
- FNY Investment Advisers's Spark Therapeutics, Inc. Common Stock position peaked at $31.9M in Q1 2019.
- 0 funds tracked by Wall St. Rank held Spark Therapeutics, Inc. Common Stock as of Q4 2019.
Based on FNY Investment Advisers's 13F filing for Q4 2019, filed 10 Jan 2020.